Fidelity Disruptive Medicine ETF (FMED)Health | Exchange Traded Fund | NasdaqGM
29.07 USD
-0.47
(-1.605%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 29.07 +0.08 (0.261%) ⇧ (July 13, 2026, 4:10 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 4:31 a.m. EDT
The Fidelity Disruptive Medicine ETF is currently trapped in a structural downtrend that outweighs its recent technical bounce. While the price has rallied sharply over the last two weeks, breaking above key moving averages, this move is occurring against a backdrop of two consecutive years of negative annual returns and a cumulative decline of over 4%. This is not a classic 'dead cat bounce'; the market has consistently reassessed the business quality downward, evidenced by the persistent price drift despite the sector's broader themes. The lack of options activity confirms that neither bulls nor bears are actively positioning for a breakout or a crash, leaving the ETF in a state of low-liquidity stagnation. For a long-term investor, the multi-year decline is a significant red flag regarding the underlying portfolio's performance relative to peers, capping the long-term rating despite the recent price recovery. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.029166 |
| AutoETS | 0.029169 |
| AutoTheta | 0.029467 |
| MSTL_59 | 0.031964 |
| MSTL | 0.032802 |
| MSTL_59_95 | 0.040181 |
| MSTL_95 | 0.041407 |
Forecast horizon: 60 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 45% |
| H-stat | 2.59 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 2.43 |
| Attribute | Value |
|---|---|
| Trailing P/E | 41.19 |
As of July 11, 2026, 4:31 a.m. EDT: Speculator positioning is extremely light and ambiguous. Call volume is negligible across all strikes, with open interest concentrated in deep out-of-the-money contracts rather than actionable near-term targets. The absence of put buying suggests no defensive hedging, while the lack of call aggression indicates a lack of bullish conviction. Implied volatility is flat, reflecting a market that sees little immediate directional risk or opportunity.
| Date | Dividend | Yield % |
|---|---|---|
| 2024-12-20 | 0.112 | 0.447463 |
| 2024-06-21 | 0.001 | 0.004212 |
| Attribute | Value |
|---|---|
| All Time High | 30.33 |
| All Time Low | 19.88 |
| Ask | 37.28 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 11,360 |
| Average Daily Volume3 Month | 18,521 |
| Average Volume | 18,521 |
| Average Volume10Days | 11,360 |
| Beta3 Year | 0.8 |
| Bid | 21.19 |
| Bid Size | 2 |
| Category | Health |
| Crypto Tradeable | 0 |
| Currency | USD |
| Custom Price Alert Confidence | HIGH |
| Day High | 29.42 |
| Day Low | 28.78 |
| Dividend Yield | 0.0 |
| Eps Trailing Twelve Months | 0.70557725 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 25.91764 |
| Fifty Day Average Change | 3.148159 |
| Fifty Day Average Change Percent | 0.12146781 |
| Fifty Two Week Change Percent | 23.230219 |
| Fifty Two Week High | 30.33 |
| Fifty Two Week High Change | -1.2642002 |
| Fifty Two Week High Change Percent | -0.04168151 |
| Fifty Two Week Low | 22.802 |
| Fifty Two Week Low Change | 6.2637997 |
| Fifty Two Week Low Change Percent | 0.27470395 |
| Fifty Two Week Range | 22.802 - 30.33 |
| First Trade Date Milliseconds | 1,686,576,600,000 |
| Five Year Average Return | -0.0014154001 |
| Full Exchange Name | NasdaqGM |
| Fund Family | Fidelity Investments |
| Fund Inception Date | 1,586,995,200 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Has Pre Post Market Data | 1 |
| Ipo Expected Date | 2,023-06-12 |
| Language | en-US |
| Legal Type | Exchange Traded Fund |
| Long Business Summary | The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified. |
| Long Name | Fidelity Disruptive Medicine ETF |
| Market | us_market |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_647865790 |
| Nav Price | 30.15206 |
| Net Assets | 46,404,236.0 |
| Net Expense Ratio | 0.5 |
| Open | 29.42 |
| Post Market Change | 0.07579994 |
| Post Market Change Percent | 0.26146927 |
| Post Market Price | 29.0658 |
| Post Market Time | 1,783,973,404 |
| Previous Close | 29.54 |
| Price Hint | 2 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | ETF |
| Region | US |
| Regular Market Change | -0.4742012 |
| Regular Market Change Percent | -1.6052849 |
| Regular Market Day High | 29.42 |
| Regular Market Day Low | 28.78 |
| Regular Market Day Range | 28.78 - 29.42 |
| Regular Market Open | 29.42 |
| Regular Market Previous Close | 29.54 |
| Regular Market Price | 29.0658 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 25,054 |
| Short Name | Fidelity Disruptive Medicine ET |
| Source Interval | 15 |
| Symbol | FMED |
| Three Year Average Return | 0.0740302 |
| Total Assets | 46,404,236 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing P E | 41.194355 |
| Trailing Peg Ratio | None |
| Trailing Three Month Nav Returns | 16.29596 |
| Trailing Three Month Returns | 16.29596 |
| Triggerable | 1 |
| Two Hundred Day Average | 26.170565 |
| Two Hundred Day Average Change | 2.895235 |
| Two Hundred Day Average Change Percent | 0.11062945 |
| Type Disp | ETF |
| Volume | 25,054 |
| Yield | 0.0 |
| Ytd Return | 5.47597 |